When was BioSerenity founded?

BioSerenity was founded in 2014 and raised its 1st funding round 1 year after it was founded.

Where is BioSerenity located?

BioSerenity is headquartered in Paris, France.

How many employees does BioSerenity have?

As of Aug 31, 2026, the latest employee count at BioSerenity is 6.

Is BioSerenity a funded company?

BioSerenity is a funded company, having raised a total of $121M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jun 04, 2015.

When was the latest funding round of BioSerenity?

BioSerenity's latest funding was a $***** PE round on Nov 13, 2023, with participation from 1 investor.

Where does BioSerenity rank among its competitors?

BioSerenity ranks 18th amongst 202 active competitors, of which 67 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Neurosoft Bioelectronics, which secured $7.5M in May, 2026.

Who are the top competitors of BioSerenity?

BioSerenity's top competitors include Ceribell, Empatica and Beacon Biosignals. Among them, Neurosoft Bioelectronics secured the most recent funding round in May, 2026.

BioSerenity - 2026 Company Profile, Team, Funding & Competitors

BioSerenity is a series B company based in Paris (France), founded in 2014 by Pierre Frouin. It operates as a Provider of smart healthcare solutions for sleep and EEG lab management. BioSerenity has raised $121M in funding from investors like Dassault Systems, Idinvest Partners and Jolt Capital. The company has 202 active competitors, including 67 funded and 11 that have exited. Its top competitors include companies like Ceribell, Empatica and Beacon Biosignals.

Company Details

Provider of smart healthcare solutions for sleep and EEG lab management. The company offers a comprehensive software solution that enables healthcare providers to manage sleep and EEG labs, with features such as scheduling, HST processing, and remote patient communication. Also, it offers ICECAP an EEG device for inpatient or outpatient testing.

Website: bioserenity.com
Social

Key Metrics

Founded Year

2014

Location

Paris, France

Stage

Series B

Total Funding

$121M in 4 rounds

Latest Funding Round

PE, Nov 13, 2023, $*****

Investors

Dassault Systems & 8 more

Ranked

18^th among 202 active competitors

Employee Count

6 as on Aug 31, 2026

Investment & Acquisitions

BOYDSense

Similar Companies

Ceribell & 240 more

View BioSerenity's full profile

BioSerenity is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Bioserenity Medical Devices Group CIN: 980872105 , France, Active	Oct 27, 2023	-	-	-

BioSerenity has raised a total funding of $121M over 4 rounds. Its first funding round was on Jun 04, 2015. Its latest funding round was a PE round on Nov 13, 2023 for $*****. 1 investor participated in its latest round. BioSerenity has 9 institutional investors.

Here is the list of recent funding rounds of BioSerenity:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 13, 2023	3461956	PE	3669695	7615980	6555037	2519124
Jun 18, 2019	1769862	Series B	4921630	7582836	8258630	LBO France & 2 more
Sep 20, 2017	6402516	Series A	1349125	3272306	LBO France	Idinvest Partners & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of BioSerenity's funding rounds and investors

The founders of BioSerenity is Pierre Frouin. Jean-Yves Lagarde is the CEO of BioSerenity.

Here are the details of BioSerenity's key team members:

Pierre Frouin: Founder / CEO of BioSerenity.
Contact Info: 1 email address

View details of BioSerenity's Founder profiles and Board Members

BioSerenity's employee count trend

BioSerenity has 6 employees as of Aug 26. Here is BioSerenity's employee count trend over the years:

Uncover BioSerenity's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of BioSerenity include Ceribell, Empatica and Beacon Biosignals. Here is the list of Top 10 competitors of BioSerenity, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Ceribell 2014, Mountain View (United States), Public	EEG system for the diagnosis of seizures	$188M	The Rise Fund, Longitude Capital & 11 others	69/100
2nd	Empatica 2011, Milano (Italy), Series B	Developer of a wrist band to monitor physiological signals	$30.9M	RA Capital Management, Sanofi Ventures & 5 others	66/100
3rd	Beacon Biosignals 2019, Boston (United States), Series B	AI-based EEG analysis and diagnosis platform for healthcare providers	$141M	General Catalyst, Logos & 11 others	63/100
4th	Emotiv 2011, San Francisco (United States), Seed	Manufacturer of wireless EEG headsets and software solutions	$7.41M	Disney Accelerator, The Wells Investment & 3 others	58/100
5th	BrainScope 2006, Bethesda (United States), Series B	Provider of AI-powered non-invasive medical devices for diagnosing and assessing brain injuries, including concussions and brain bleeds	$62.2M	Maryland Venture Fund, Aon & 11 others	58/100
6th	BrainCo 2015, Somerville (United States), Series A	Provider of a prosthetic hand and EEG headband for brain signal	$292M	Walden International, IDG Capital & 10 others	58/100
7th	Cumulus Neuro 2015, Belfast (United Kingdom), Series A	AI and cloud-based brain physiology analysis tool for clinical trials	$19.6M	Par Equity, Innovate UK & 29 others	57/100
8th	Spark Biomedical 2018, Houston (United States), Series A	Developer of wearable neurostimulation technology for drug-free opioid withdrawal treatment	$31.2M	Wave Ventures, Wellcome Leap & 5 others	56/100
9th	Neurosoft Bioelectronics 2019, Geneva (Switzerland), Seed	Provider of soft implantable electrodes for neurological disorders	$20M	Fongit, IAG Capital Partners & 6 others	55/100
10th	Cortical Labs 2019, Melbourne (Australia), Series A	Manufacturer of AI-powered biochips	$11.6M	Horizons Ventures, January Capital & 9 others	55/100
18th	BioSerenity 2014, Paris (France), Series B	Provider of smart healthcare solutions for sleep and EEG lab management	$121M	LBO France, Kurma Partners & 7 others	47/100